Some of the leading life insurance companies have reported a sharp decline in the number of lives covered in FY25, largely due to a slowdown in credit-linked life insurance policies. Stress in the microfinance segment has reduced loan disbursements and, in turn, the flow of new customers to insurers.
The paintings were sold for a record Rs 100 crore to Mumbai-based businessman Guru Swarup Srivastava. \nSrivastava will auction the first 25 paintings on May 8.
Industrialist and art dealer Guru Swarup Srivastava was today remanded to police custody till May 21 by a local court for allegedly forging documents.
The Securities Appellate Tribunal (SAT) on Monday set aside the penalty imposed by Sebi on Reliance Industries Ltd's chairman Mukesh Ambani and two other entities in a case related to alleged manipulative trading in the shares of erstwhile Reliance Petroleum Ltd (RPL) back in November 2007. The ruling has come after all the entities appealed before the tribunal against the order passed by the Securities and Exchange Board of India (Sebi) in January 2021. In January 2021, Sebi imposed a Rs 25 crore fine on Reliance Industries Ltd(RIL), Rs 15 crore on Ambani, who is the company's chairman and managing director, Rs 20 crore on Navi Mumbai SEZ Pvt Ltd and Rs 10 crore on Mumbai SEZ Ltd in RPL case.
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.
Non-mineral-rich states will benefit from tariff concessions.
Anil Swarup, who conceived the Rashtriya Swasthya Bima Yojana -- a scheme the United Nations Development Programme and the International Labour Organisation recognised as among the finest -- speaks to Anjuli Bhargava.
In the next few weeks, the Bombay High Court will hear the institute's petition to review its 2011 directive to vacate the land it occupies in Film City.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances